IP Library Granted Patent US 9,381,160
Granted Patent B2
US 9,381,160 · App. 14/320,066 · Granted Jul 5, 2016

Sustained release beads and suspensions including the same for sustained delivery of active ingredients

Inventor: Robert Niichel (Greenwood Village, CO)
Assignee: NANO PHARMACEUTICAL LABORATORIES, LLC
A61K9/1652A23L1/0023A23L1/052A23L1/30A23L1/302A23L1/304A23L2/52A61K9/16A61K9/50A61K9/5047A61K31/00A61K31/522A61K33/00A61K33/14A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,381,160
App. No.
14/320,066
Granted
Jul 5, 2016
Kind
B2
Abstract

Sustained-released beads providing active ingredients over an extended period of time to an individual orally ingesting the sustained release beads. The sustained-release beads can be part of a suspension wherein the sustained-release beads are suspended and evenly dispersed in the suspension. Binding agents are used to form the structural framework of the sustained released beads and retain the active ingredients without chemical or electrical bonding. The components of the dispersion medium are GRAS designated, making the suspension suitable for use as a food product.

Claims (21)

1. A suspension comprising:

one or more sustained-release beads, each of the sustained-release beads comprising:

an uncoated core, comprising:

40 wt % to 95 wt % of one or more binding agents; and

5 wt % to 60 wt % of one or more active ingredients consisting of one or more of stimulants, electrolytes, vitamins, and minerals;

wherein the one or more binding agent and the one or more active ingredients are mixed together throughout the core; and

a dispersion medium comprising:

an aqueous solution; and

one or more thickening agents;

wherein the dispersion medium is free of the one or more active ingredients present in the core.

2. The suspension as claimed in claim 1 , wherein the one or more binding agents are selected from the group consisting of methyl cellulose, ethyl cellulose, microcrystalline cellulose, croscarmellose sodium, dicalcium phosphate, cellulose, hypromellose, hydroxypropyl methylcellulose, carboxymethylcellulose, and hydroxyethyl cellulose.

3. The suspension as claimed in claim 1 , wherein the one or more thickening agents are selected from the group consisting of agar agar, xanthan gum, guar gum, gelatin, acacia gum, pectin, ester gum, Arabic gum, and gellan gum.

4. The suspension as claimed in claim 1 , wherein the total amount of thickening agent in the dispersion medium ranges from 0.05 wt % to 2.0 wt % of the dispersion medium and the aqueous solution ranges from 75 wt % to 99.5 wt % of the dispersion medium.

5. The suspension as claimed in claim 1 , wherein the suspension includes only ingredients that are GRAS-compliant.

6. The suspension as claimed in claim 1 , wherein the diameter of sustained-release beads is in the range of from 0.5 mm to 5 mm.

7. The suspension as claimed in claim 1 , wherein the one or more sustained-release beads includes first sustained-release beads and second sustained-release beads and wherein the composition of active ingredients in the first sustained-release beads is different from the composition of active ingredients in the second sustained-release beads.

8. The suspension as claimed in claim 1 , wherein the one or more sustained-release beads includes first sustained-release beads and second sustained-release beads and wherein the first sustained-release beads release the one or more active ingredients contained therein at a rate different from the rate at which the second sustained-release beads release the one or more active ingredients contained therein.

9. The suspension as claimed in claim 1 , wherein the one or more sustained-release beads includes first sustained-release beads and second sustained-release beads;

wherein the composition of active ingredients in the first sustained-release beads is different from the composition of active ingredients in the second sustained-release beads; and

wherein the first sustained-release beads release the one or more active ingredients contained therein at a rate different from the rate at which the second sustained-release beads release the one or more active ingredients contained therein.

10. The suspension as claimed in claim 1 , wherein the stimulant is caffeine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2014
From: NIICHEL, ROBERT
To: NANO PHARMACEUTICAL LABORATORIES LLC
Reel/Frame 033241/0734 →
Continuity (3)
Continuation 13974664 · Aug 23, 2013
Division 12492995 · Jun 26, 2009
Related Publication 20140314856A1 · Oct 23, 2014